Clinical Trial Update: Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating directed high-dose nasal corticosteroids for residual smell loss after sinus surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Olfactory Disorders
• Paranasal Sinus Diseases
• Sinusitis

Drugs mentioned

• Intranasal corticosteroids (intranasal corticosteroids)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Olfaction Disorders, Sinusitis | Phase 2 | Status: WITHDRAWN